Quantification of cidofovir in human serum by LC-MS/MS for children

被引:9
作者
Breddernann, Andre [1 ]
Hsien, Linda [1 ]
Tot, Edith [1 ]
Laeer, Stephanie [1 ]
机构
[1] Univ Dusseldorf, Dept Clin Pharm & Pharmacotherapy, D-40225 Dusseldorf, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 861卷 / 01期
关键词
cidofovir; PMEG; LC-MS/MS; pharmacokinetic study; children;
D O I
10.1016/j.jchromb.2007.11.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new method for the quantification of cidofovir (CDV), an acyclic nucleotide analogue of cytosine with antiviral activity against a broad-spectrum of DNA viruses, in human serum, using high-performance liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has been developed. A strong anion exchange (SAX) solid-phase extraction procedure was applied for the sample preparation. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z 278.1 -> 234.9 and the m/z 288.1 -> 133.1 transitions for CDV and the internal standard 9-(2-phosphonylmethoxyethyl)guanine (PMEG), respectively, using negative electrospray ionization. The MS/MS response was linear over the concentration range from 78.125 ng/ml to 10,000 ng/ml, with a lower limit of quantification of 78.125 ng/ml. The intra- and inter-day precisions (relative standard deviation (%)) for CDV were less than 7.8% and the accuracies (% of deviation from nominal level) were within +/- 12.1% for quality controls. The novel LC-MS/MS method allowed a specific, sensitive and reliable determination of CDV in human serum and was applied to investigate the yet unknown pharmacokinetic properties of CDV in a paediatric cancer patient. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 21 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   Separation methods for antiviral phosphorus-containing drugs [J].
Ba, BB ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B, 2001, 764 (1-2) :349-362
[3]  
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO
[4]  
2-0
[5]  
Breddemann Andre, 2007, Herpes, V14, P41
[6]   Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis [J].
Brody, SR ;
Humphreys, MH ;
Gambertoglio, JG ;
Schoenfeld, P ;
Cundy, KC ;
Aweeka, FT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) :21-28
[7]   CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
CUNDY, KC ;
PETTY, BG ;
FLAHERTY, J ;
FISHER, PE ;
POLIS, MA ;
WACHSMAN, M ;
LIETMAN, PS ;
LALEZARI, JP ;
HITCHCOCK, MJM ;
JAFFE, HS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1247-1252
[8]   Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir [J].
Cundy, KC .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :127-143
[9]   High-performance liquid chromatographic determination of cytosine-containing compounds by precolumn fluorescence derivatization with phenacyl bromide: Application to antiviral nucleosides and nucleotides [J].
Eisenberg, EJ ;
Cundy, KC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 679 (1-2) :119-127
[10]  
Eksborg Staffan, 2003, Herpes, V10, P66